Serina Therapeutics Stock Price, News & Analysis
ser
NYSE
Company Description
Welcome to the overview page for Serina Therapeutics (ser), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
Latest News
SEC Filings
Insider Radar
Net Sellers
90-Day Summary
0
Shares Bought
95,280
Shares Sold
30
Transactions
Most Recent Transaction
Moreadith Randall
(Chief Scientific Officer)
sold
1,084 shares
@ $2.50
on Jan 14, 2026
Based on SEC Form 4 filings over the last 90 days.
Financial Highlights
$56,000
Revenue (TTM)
-$11,207,000
Net Income (TTM)
-$1.51
-$17,137,000
Operating Cash Flow
-20,012.50%
-30,442.86%
Upcoming Events
FEB
08
February 8, 2026
Regulatory
NYSE compliance plan submission
Submit compliance plan to NYSE American to address listing deficiencies and avoid delisting.
JUL
09
July 9, 2027
Regulatory
Deadline to regain NYSE compliance
End of 18-month cure period to regain NYSE American listing compliance; failure may trigger delisting.
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of Serina Therapeutics (ser)?
The current stock price of Serina Therapeutics (ser) is $2.69 as of January 15, 2026.
What is the market cap of Serina Therapeutics (ser)?
The market cap of Serina Therapeutics (ser) is approximately 28.5M. Learn more about what market capitalization means .
What is the revenue (TTM) of Serina Therapeutics (ser) stock?
The trailing twelve months (TTM) revenue of Serina Therapeutics (ser) is $56,000.
What is the net income of Serina Therapeutics (ser)?
The trailing twelve months (TTM) net income of Serina Therapeutics (ser) is -$11,207,000.
What is the earnings per share (EPS) of Serina Therapeutics (ser)?
The diluted earnings per share (EPS) of Serina Therapeutics (ser) is -$1.51 on a trailing twelve months (TTM) basis. Learn more about EPS .
What is the operating cash flow of Serina Therapeutics (ser)?
The operating cash flow of Serina Therapeutics (ser) is -$17,137,000. Learn about cash flow.
What is the profit margin of Serina Therapeutics (ser)?
The net profit margin of Serina Therapeutics (ser) is -20,012.50%. Learn about profit margins.
What is the operating margin of Serina Therapeutics (ser)?
The operating profit margin of Serina Therapeutics (ser) is -30,442.86%. Learn about operating margins.
What is the current ratio of Serina Therapeutics (ser)?
The current ratio of Serina Therapeutics (ser) is 2.40, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the operating income of Serina Therapeutics (ser)?
The operating income of Serina Therapeutics (ser) is -$17,048,000. Learn about operating income.